ClinConnect ClinConnect Logo
Search / Trial NCT05598983

Non-contact Proactive Remote Monitoring of COPD Exacerbations

Launched by LIFE DETECTION TECHNOLOGIES · Oct 26, 2022

Trial Information

Current as of April 30, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to monitor patients with Chronic Obstructive Pulmonary Disease (COPD) to help detect when their condition might be getting worse, even before they feel any symptoms. The study will see if a special device called DistaSense, which is placed on top of your mattress, can pick up signs of a COPD flare-up while you sleep. You'll also complete a daily questionnaire called a CAT, which helps track how you're feeling.

To join this study, you need to be at least 18 years old, have a confirmed diagnosis of COPD, and have experienced at least one flare-up in the past year. Participants will need to be comfortable using the monitoring device and completing the daily questionnaires. This research is important because it could lead to earlier interventions for COPD flare-ups, potentially improving patients' health and quality of life.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Confirmed diagnosis of COPD
  • 2. 1 or more exacerbation in the last year
  • 3. Aged over 18 years
  • 4. Willing to use monitoring devices and complete study questionnaires
  • 5. Adequate English
  • 6. Signed consent form
  • Exclusion Criteria:
  • 1. Pregnancy
  • 2. BMI greater than 45 kg/m2
  • 3. Nil other, provided inclusion criteria are met.

About Life Detection Technologies

Life Detection Technologies is an innovative clinical trial sponsor dedicated to advancing the field of biosensing and diagnostic solutions. With a focus on developing cutting-edge technologies for the early detection of diseases, the company leverages interdisciplinary expertise in engineering, biology, and data analytics. Through rigorous clinical trials and research initiatives, Life Detection Technologies aims to enhance patient outcomes and contribute to the precision medicine landscape. Committed to ethical practices and regulatory compliance, the organization fosters collaboration with healthcare professionals and research institutions to drive the translation of scientific discoveries into practical applications.

Locations

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

John Hurst

Principal Investigator

University College, London

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials